Incoming Third Wave CEO Kevin Conroy on Company s Path Ahead | GenomeWeb

Name: Kevin Conroy

Position: Incoming CEO and director, Third Wave Technologies

Background: Vice president of legal affairs, vice president and general counsel, Third Wave Technologies, 2004-2006

Team manager, GE Healthcare, 2000-2004

Education: JD, University of Michigan


Just before the holiday season, Third Wave announced its CEO, John Puisis, would step down as part of the company's transition from a research-tools company to a pure-play molecular diagnostics firm.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.